Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Infliximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 8 Melanoma 6 Colitis, Ulcerative 6 Inflammatory Bowel Diseases 5 Crohn Disease 5 Carcinoma, Non-Small-Cell Lung 4 Lung Neoplasms 3 Colitis 3 Urogenital Neoplasms 2 Inflammation 2 Hematologic Neoplasms 2 Graft vs Host Disease 2 Fatigue 2 Depressive Disorder, Major 2 Depression 2 Cachexia 2 Anorexia 2 Vasculitis 1 Takayasu Arteritis 1 Syndrome 1 Stroke 1 Stevens-Johnson Syndrome 1 Spondylitis, Ankylosing 1 Skin Neoplasms 1 Recurrence 1 Rare Diseases 1 Psoriasis 1 Precancerous Conditions 1 Pemphigoid, Benign Mucous Membrane 1 Pancreatic Neoplasms 1

Interventions

Cyclophosphamide 152 Dexamethasone 140 Rituximab 84 fludarabine 79 Lenalidomide 72 Cytarabine 70 fludarabine phosphate 63 Bortezomib 63 Gemcitabine 62 venetoclax 54 Etoposide 53 pomalidomide 51 pembrolizumab 51 Paclitaxel 48 Cisplatin 48 Carboplatin 48 Peripheral Blood Stem Cell Transplantation 47 Filgrastim 40 Radiotherapy 39 Busulfan 37 Calcium Dobesilate 36 Methotrexate 34 Melphalan 34 Bevacizumab 33 carfilzomib 32 Cyclosporine 32 Azacitidine 32 Mycophenolic Acid 30 Nivolumab 29 Bendamustine Hydrochloride 29

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03011268 2025-05-31

BIOSTOP

Helse Møre og Romsdal HF

Phase NA Completed

Colitis, Ulcerative, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡